Make a referral

PRESS RELEASE: Workit Health Announces New Board Member to Support New Phase of Growth

A future free of addiction is in your hands

Recover from addiction at home with medication, community, and support—from the nonjudmental experts who really care.

What's your goal?

Join the 23k+ members who treated addiction via their phone

In this article

Ben Slocum adds 36 years of healthcare industry expertise to digital addiction care company Workit Health’s board of experts.

Workit Health, a digital healthcare company offering FDA-approved medication and evidence-based addiction treatment via web and phone apps, today announced the expansion of its board with Ben Slocum as the newest member.

Slocum’s appointment comes after Workit Health’s Series A round of funding, led by Blue Cross Blue Shield Ventures, and rapid growth of the company’s tele-MAT program in 2019. Ben Slocum brings 36 years of healthcare experience to Workit Heath’s disruptive digital solutions, which offer improved outcomes for health plans, employers, and individuals at significantly lower costs than traditional systems of care.

As a former C-level executive at several health plans, Ben focused on increasing consumer engagement and improving outcomes for complex health conditions. In his previous roles as CEO of WebMD Health Services, CEO of United Healthcare, Northern California, and CEO of Lovelace Health Plan, he spearheaded major innovations with member experience at the forefront. He’s held leadership roles in consumer, employer, government, and provider settings.

“Ben Slocum’s experience in the healthcare industry will continue to help us expand our reach to more health plans and consumers while also prioritizing innovation and improvements for our members,” said Robin McIntosh, Workit Health’s Co-CEO. “As more health plans partner with Workit Health, we’re able to improve the lives of people struggling with addiction and ultimately to reduce the costs of the addiction epidemic nationwide.”

“On behalf of Workit Health and our current directors, I’m excited to welcome Ben to the board,” said Lisa McLaughlin, Workit Health’s Co-CEO. “2019 was a big year for us in terms of growth and partnerships, and Ben joining our team further validates Workit Health’s value to health plans, employers, and individuals.”

About Workit Health: Workit Health is a Joint Commission-accredited B-Corporation offering online, on-demand evidence-based addiction treatment including telemedicine medication for opioid and alcohol use disorders. We partner with healthcare organizations to deliver an innovative digital health solution that blends the best of human-centered design, technology, and science. Through our mobile and web apps, members meet with clinicians and counselors, join recovery groups, and complete self-set recovery goals. Our interactive curriculum of online courses keep members on track in the comfort of home. We offer 24/7 recovery that fits into daily life, designed by experts. For more information, visit


As Workit Health’s Head of Marketing, Kali Lux leans in to the culture gap between addiction, recovery, and medicine. She’s interested in finding solutions that work for substance users better than drinking or drugging does, and believes Workit is one of them. She’s written extensively on her own experience through addiction into long-term recovery. You can connect with her on Twitter @kalireadsbooks.

Any general advice posted on our blog, website, or app is for informational purposes only and is not intended to replace or substitute for any medical or other advice. Workit Health, Inc. and its affiliated professional entities make no representations or warranties and expressly disclaim any and all liability concerning any treatment, action by, or effect on any person following the general information offered or provided within or through the blog, website, or app. If you have specific concerns or a situation arises in which you require medical advice, you should consult with an appropriately trained and qualified medical services provider.

This site uses cookies to improve your experience. By using this site, you consent to our use of cookies.